NEXI (NexImmune) Insider Ownership: 16.45 % (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NexImmune Insider Ownership?

NexImmune NEXI Insider Ownership is 16.45 % as of Aug. 28, 2026.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NexImmune's insider ownership is 16.45%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NexImmune's Institutional Ownership is 0.77%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NexImmune's Float Percentage Of Total Shares Outstanding is 90.20%.

NexImmune Insider Ownership Historical Data

* Premium members only.

The historical data trend for NexImmune's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NexImmune Insider Ownership Chart

NexImmune Historical Data

The historical data trend for NexImmune can be seen below:

2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30
Insider Ownership 14.63 14.63 14.63 16.45 16.45 16.45 16.45 16.45 16.45 16.45

NexImmune Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 16.45 % mean?
NexImmune (NEXI) has a Insider Ownership of 16.45 % as of Aug. 28, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on NexImmune and its competitors.
Is NexImmune's Insider Ownership too high?
NexImmune's current Insider Ownership is 16.45 %.
How does NexImmune's Insider Ownership compare to PPCBD and ENDV?
NexImmune's Insider Ownership of 16.45 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on NexImmune and its competitors. NexImmune's current Insider Ownership is 16.45 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NexImmune stock overvalued right now?
NexImmune (NEXI) has a current Insider Ownership of 16.45 %. The current Insider Ownership is 16.45 %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For NexImmune (NEXI), the current Insider Ownership is 16.45 % as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NexImmune Business Description

Address 9119 Gaither Road, Gaithersburg, MD, USA, 20877
NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body's T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.